Emerging Biotech achieves successful European launch with support of Orphan Drug Consulting’s comprehensive approach to navigating diverse market landscape and EU regulations
As rare disease companies continue to face the challenge of entering new markets without adequate infrastructure build and knowhow, Orphan Drug Consulting experts recently supported one such company with an accelerated launch into the EU market. Using its cross-functional team and proven approach, Orphan Drug Consulting enabled early access of the client’s treatment to […]
World Orphan Drug Congress Europe 2023
Join us at World Orphan Drug Congress Europe 2023 30 Oct -2 Nov 2023 Orphan Drug Consulting is delighted to be attending World Orphan Drug Congress Europe 2023 in Barcelona at Fira de Barcelona – Montjuïc from 30th October – 2nd November 2023. The team is looking forward to meeting industry leading experts and discussing […]
WEBINAR: Navigating Recent ATU Changes in France
Key Implications for Successful Early Access Programmes in the French Market August 28, 2023. 12:00PM EST/ 5.00PM GMT Orphan Drug Consulting is hosted a webinar with Intsel Chimos titled “Navigating Recent ATU Changes in France: Key Implications for Organisations Entering the French Market.” Jason Cameron, COO of Orphan Drug Consulting, and Corinne Truffault, CEO […]